EUCTR2005-002772-14-IT进行中（未招募）不适用
A 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel group trial of lumiracoxib COX189 100 mg o.d. in patients with primary hip osteoarthritis using celecoxib 200 mg o.d. as a positive control
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A 13-week, multicenter, randomized, double-blind, double-dummy,placebo-controlled, parallel group trial oflumiracoxib (COX189) 100 mg o.d. in patients with primaryhip osteoarthritis using celecoxib (200 mg o.d.) as apositive controlMedDRA version: 8.0Level: LLTClassification code 10020108Primary osteoarthritis of the hipEUCTR2005-002772-14-DEovartis Pharma Services AG1,200
进行中（未招募）
1 期
A 13-week, multicenter, randomized, double-blind, doubledummy, placebo-controlled, parallel group trial of lumiracoxib (COX189) 100 mg o.d. in patients with primary hip osteoarthritis using celecoxib (200 mg o.d.) as a positive controlPrimary osteoarthritis of the hipMedDRA version: 8.0 Level: LLT Classification code 10020108EUCTR2005-002772-14-GBovartis Pharma Services AG
未知
3 期
Double-blind study of treatment with LCZ696 in asian elderly patients with essential hypertensioEssential HypertensionJPRN-jRCT2080221938ovartis Pharma K.K.576
招募中
不适用
Effect of bamboo shavings (Phyllostachyos Caulis in Taeniam) extract on improvement of height growthKCT0001714Korea Medicine Research Institute60
已完成
不适用
Human body test for evaluating the efficacy and safety of white ginseng extract for liver functioSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0004080International Ginseng & Herb Research Institute60